McKesson (NYSE:MCK) Updates FY25 Earnings Guidance

McKesson (NYSE:MCK) updated its FY25 earnings guidance on Tuesday. The company provided EPS guidance of $31.25-$32.05 for the period, compared to the consensus EPS estimate of $31.09. The company issued revenue guidance of $355.35-$361.53 billion, compared to the consensus revenue estimate of $341.05 billion.

McKesson Stock Performance

McKesson stock traded up $11.12 during trading hours on Tuesday, hitting $544.53. 983,843 shares of the stock were exchanged, compared to its average volume of 705,665. The business’s 50-day moving average is $531.17 and its two-hundred day moving average is $493.81. McKesson has a 12 month low of $364.08 and a 12 month high of $546.63. The stock has a market capitalization of $71.56 billion, a P/E ratio of 24.67, a P/E/G ratio of 1.41 and a beta of 0.45.

McKesson (NYSE:MCK) last announced its quarterly earnings data on Wednesday, February 7th. The company reported $7.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.05 by $0.69. The firm had revenue of $80.90 billion for the quarter, compared to analysts’ expectations of $77.93 billion. McKesson had a net margin of 0.99% and a negative return on equity of 262.63%. The business’s revenue for the quarter was up 14.8% on a year-over-year basis. During the same period last year, the firm earned $6.90 earnings per share. On average, equities analysts predict that McKesson will post 27.59 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Monday, June 3rd will be paid a dividend of $0.62 per share. The ex-dividend date is Friday, May 31st. This represents a $2.48 dividend on an annualized basis and a dividend yield of 0.46%. McKesson’s payout ratio is presently 11.24%.

Wall Street Analysts Forecast Growth

MCK has been the topic of a number of research reports. SVB Leerink initiated coverage on McKesson in a research report on Monday, February 26th. They set an outperform rating and a $600.00 price objective on the stock. UBS Group lifted their target price on shares of McKesson from $575.00 to $620.00 and gave the stock a buy rating in a research note on Wednesday, March 6th. Citigroup upped their price target on shares of McKesson from $575.00 to $620.00 and gave the company a buy rating in a research report on Tuesday, April 30th. StockNews.com raised McKesson from a buy rating to a strong-buy rating in a research report on Saturday. Finally, Morgan Stanley upped their target price on McKesson from $522.00 to $548.00 and gave the company an overweight rating in a research report on Monday, April 15th. Two analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, McKesson currently has an average rating of Moderate Buy and a consensus price target of $536.71.

Insiders Place Their Bets

In other McKesson news, EVP Leann B. Smith sold 186 shares of the firm’s stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total transaction of $92,256.00. Following the completion of the transaction, the executive vice president now owns 1,511 shares of the company’s stock, valued at $749,456. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other McKesson news, CEO Brian S. Tyler sold 3,473 shares of McKesson stock in a transaction on Friday, March 15th. The stock was sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the completion of the transaction, the chief executive officer now owns 43,445 shares in the company, valued at $22,789,074.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Leann B. Smith sold 186 shares of the stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total value of $92,256.00. Following the completion of the sale, the executive vice president now directly owns 1,511 shares in the company, valued at $749,456. The disclosure for this sale can be found here. 0.21% of the stock is currently owned by insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.